Medable, founded in 2015, is a technology company focused on clinical trial infrastructure. Its core product, the Medable Platform, is an end-to-end cloud-based system designed for pharmaceutical sponsors, contract research organizations (CROs), healthcare providers, and patients to collaborate on clinical trials. The platform incorporates agentic AI and study management tools to streamline trial design and execution.
The company operates across several technical domains, including agentic AI, electronic Clinical Outcome Assessment (eCOA), and decentralized clinical trial solutions. Its platform claims to enable sponsors to build studies up to 35 times faster through its Studio and AI technology. The company's stated vision includes ambitious timelines for one-day study startup and one-day patient enrollment.
Medable's industry verticals span pharmaceutical, biotechnology, and CRO sectors. The company maintains a global geographic presence and adheres to international regulatory standards, holding certifications for HIPAA, GDPR, ISO, FDA 21 CFR Part 11, and ICH E6(R2) GCP. It was founded by a physician-scientist motivated by the challenges of patient access in clinical research.
